UPDATE: Exact Sciences Posts 17 Percent Q4 Revenue Increase | GenomeWeb

The story has been updated to include comments from company officials from a conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today reported revenues of $1.4 million for the fourth quarter, an increase of almost 17 percent from revenues of $1.2 million for the fourth quarter of 2009.

The firm beat consensus Wall Street expectations of $1.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.